July 21, 2015

Horizon Pharma raises bid for Depomed to $33 per share

Drugmaker Horizon Pharma PLC is boosting its offer for fellow drugmaker Depomed to $33 per share.

That's up from $29.25 per share.

The Dublin-based company said Tuesday that the new offer is contingent on Depomed entering "good faith" talks on the transaction.

Depomed said in a statement that it would review the offer with independent advisers and advised shareholders not to act on the offer yet. It said the offer wouldn't result in Depomed shareholders receiving more shares but is a result of Horizon's increasing since the initial offer was made.

Last week Depomed Inc.—which had rejected Horizon's initial bid—adopted a "poison pill" plan after Horizon went hostile with its takeover offer.

Depomed, based in Newark, California, has a portfolio that includes the migraine drug Cambia and the painkiller Nucynta ER.

© 2015 The Associated Press. All rights reserved.

Citation: Horizon Pharma raises bid for Depomed to $33 per share (2015, July 21) retrieved 18 April 2024 from https://medicalxpress.com/news/2015-07-horizon-pharma-depomed.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Auxilium Pharma rejects Endo's takeover offer
4 shares

Feedback to editors
Researchers discover new therapeutic target for non-small cell lung cancer

56 minutes ago
Immune cells carry a long-lasting 'memory' of early-life pain

1 hour ago
Cannabis legalization and rising sales have not contributed to increase in substance abuse, study finds

1 hour ago
No negative impact from prolonged eye patching on child's development or family stress levels

1 hour ago
COVID-19 booster immunity lasts much longer than primary series alone, study shows

2 hours ago
Study finds that human neuron signals flow in one direction

3 hours ago
A common pathway in the brain that enables addictive drugs to hijack natural reward processing identified

3 hours ago
Scientists identify airway cells that sense aspirated water and acid reflux

3 hours ago
Environment may influence metacognitive abilities more than genetics

3 hours ago
Contracting RSV before age two can cause long-term lung changes and impairment

4 hours ago
Load comments (0)